The Glenway Health Plan's pharmacy and therapeutics (P&T) committee conducted pharmacoeconomic research to measure both the clinical outcomes and costs of two new cholesterol-reducing drugs. Results were presented as a ratio showing the cost required to produce a 1 mcg/l decrease in cholesterol levels. The type of pharmacoeconomic research that Glenway conducted in this situation was most likely
Catalina
5 months agoSina
5 months agoBeckie
5 months agoJulio
5 months agoSol
5 months agoIzetta
6 months agoLettie
6 months agoAllene
6 months ago